Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Nebulised HepArin Reduce acuTE Lung Injury in Patients With SARS-CoV-2 Requiring Respiratory Support in Ireland

NCT04511923 is registered in ClinicalTrials.gov with University College Hospital Galway as lead sponsor.

NCT NCT04511923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04511923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Nebulised HepArin Reduce acuTE Lung Injury in Patients With SARS-CoV-2 Requiring Respiratory Support in Ireland
Lead sponsor
University College Hospital Galway
Phase
Phase 1/2
Overall status
Completed
Start date
December 23, 2020
Completion date
February 28, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, human, covid19, lung injury, acute, ventilation perfusion mismatch